Angitia Incorporated Limited is a clinical-stage biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. Focusing on areas such as bone, cartilage, and muscle, Angitia leverages its team's expertise in new drug development to address unmet medical needs, bringing cutting-edge treatments to patients.
Angitia is seeking a CMC Process R&D Executive Director to lead the development of biologic products (mAb, bispecific, and ADC). This role is central to organizational decision-making and ensures scientific excellence and impact for patients. The position focuses on cell line selection, process development, scale-up, and cGMP production, ultimately impacting Phase I/II clinical supply and global regulatory submissions.
Angitia Incorporated Limited is a clinical-stage biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. Focusing on areas such as bone, cartilage, and muscle, Angitia leverages its team's expertise in new drug development to address unmet medical needs, bringing cutting-edge treatments to patients.
BioNTech SE